NR4A2 and schizophrenia: However, the haloperidol treatment group had a non-significant mean increase in BDNF IV mRNA (41.19%) and NURR1 mRNA (46.46%) compared to controls, which is the opposite direction of change found in schizophrenia cases in the human post-mortem substantia nigra.